Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

559
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
559

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-staphylococcal potential of montanine-type derivatives from amaryllidaceae alkaloids alone and in combination with antibiotics.

Journal of applied microbiology·2026
Same author

Endoglin is not a mediator in 7-ketocholesterol-induced endothelial activation in liver sinusoidal endothelial cells in vitro.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis.

Scientific reports·2026
Same author

Anti-endoglin monoclonal antibody TRC105 prevents the increase of liver inflammatory biomarkers in a mouse model of cholestasis.

Cellular and molecular life sciences : CMLS·2026
Same author

Host soluble plasma factors increase dual-species Staphylococcus epidermidis and Candida albicans biofilm biomass without enhancing stress tolerance.

Scientific reports·2026
Same author

Soluble endoglin as a biomarker of cardiovascular and metabolic disorders related to endothelial dysfunction: a systematic review and meta-analysis.

Atherosclerosis·2026

Related Experiment Video

Updated: Mar 31, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

17.4K

Soluble endoglin, hypercholesterolemia and endothelial dysfunction.

Jana Rathouska1, Katerina Jezkova1, Ivana Nemeckova1

  • 1Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic.

Atherosclerosis
|November 2, 2015
PubMed
Summary

Soluble endoglin (sEng) may indicate cardiovascular disease progression and treatment effectiveness, particularly in conditions involving endothelial dysfunction and high cholesterol. Further research is needed to confirm its role in inducing endothelial dysfunction.

Keywords:
Endothelial dysfunctionHypercholesterolemiaSoluble endoglin

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.5K
Isolation and Identification of Vascular Endothelial Cells from Distinct Adipose Depots for Downstream Applications
09:00

Isolation and Identification of Vascular Endothelial Cells from Distinct Adipose Depots for Downstream Applications

Published on: June 10, 2022

3.5K

Related Experiment Videos

Last Updated: Mar 31, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

17.4K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.5K
Isolation and Identification of Vascular Endothelial Cells from Distinct Adipose Depots for Downstream Applications
09:00

Isolation and Identification of Vascular Endothelial Cells from Distinct Adipose Depots for Downstream Applications

Published on: June 10, 2022

3.5K

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Biomarker Research

Background:

  • Soluble endoglin (sEng) is the extracellular domain of membrane endoglin.
  • sEng levels increase in pathological conditions affecting vascular endothelium.
  • Endothelial dysfunction and hypercholesterolemia are linked to cardiovascular diseases.

Purpose of the Study:

  • To review the role of sEng in cardiovascular pathologies.
  • To focus on the relationship between sEng, endothelial dysfunction, and cholesterol levels.
  • To evaluate sEng as a biomarker for cardiovascular disease progression and treatment.

Main Methods:

  • Literature review of studies on soluble endoglin.
  • Analysis of sEng's association with endothelial dysfunction.
  • Exploration of sEng's potential interactions with signaling pathways (TGF-β/eNOS, BMP-9).

Main Results:

  • sEng is discussed as a potential biomarker for cardiovascular disease progression and treatment efficacy.
  • The review highlights the connection between sEng, endothelial dysfunction, and cholesterol levels.
  • Potential interactions of sEng with TGF-β/eNOS and BMP-9 signaling pathways are addressed.

Conclusions:

  • Monitoring soluble endoglin levels may help assess cardiovascular disease progression and treatment efficacy.
  • sEng reflects conditions of endothelial dysfunction and hypercholesterolemia.
  • The role of sEng as an inducer of endothelial dysfunction requires further investigation.